A Study to Evaluate Setanaxib in Patients With Alport Syndrome
Conditions: Alport Syndrome Interventions: Drug: Setanaxib; Drug: Placebo Sponsors: Calliditas Therapeutics AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Effects of Dapagliflozin on Progression of Alport Syndrome
Conditions: Alport Syndrome Interventions: Drug: Dapagliflozin 10mg Tab Sponsors: Nanjing University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
National Registry of Rare Kidney Diseases
Conditions: Adenine Phosphoribosyltransferase Deficiency; AH Amyloidosis; AHL Amyloidosis; AL Amyloidosis; Alport Syndrome; Atypical Hemolytic Uremic Syndrome; Autoimmune Distal Renal Tubular Acidosis; Autosomal Recessive Proximal Renal Tubular Acidosis; Autosomal Recessive Distal Renal Tubular Acidosis; Autosomal Dominant Polycystic Kidney Disease; Autosomal Recessive Polycystic Kidney Disease; Bartter Syndrome; BK Nephropathy; C3 Glomerulopathy With Monoclonal Gammopathy; C3 Glomerulopathy; Calciphylaxis; Crystalglobulinaemia; Crystal-storing Histiocytosis; Cystinosis; Cystinuria; Dense Deposit Disease; Dent Disease; Den...
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)
Condition: Alport Syndrome Intervention: Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
Treatment With Metformin in Chinese Children With Alport Syndrome
Conditions: Alport Syndrome; Metformin Interventions: Drug: Metformin; Other: Placebo Sponsor: Peking University First Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials
